ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Interventional Cardiology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,163Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 61

$751K Total Retail Price of All Prescriptions

Rank: 2 out of 61

670 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

3% of this provider’s 670 patients filled at least one prescription for a schedule three drug, compared to an average of 0%.

Risky Drugs to Seniors

1% of this provider’s 9,709 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
FUROSEMIDE 532 408 1 9
AMLODIPINE BESYLATE 467 389 2 5
LISINOPRIL 449 371 3 2
SIMVASTATIN 448 377 4 8
OMEPRAZOLE 303 249 5 37
CARVEDILOL 303 228 5 1
ATORVASTATIN CALCIUM 274 228 7 7
ATENOLOL 262 228 8 18
WARFARIN SODIUM 257 225 9 11
LEVOTHYROXINE SODIUM 241 212 10 45
METOPROLOL SUCCINATE 228 206 11 6
PLAVIX 214 177 12 10
METOPROLOL TARTRATE 210 163 13 4
CLOPIDOGREL 198 157 14 3
CRESTOR 198 166 14 14
ISOSORBIDE MONONITRATE ER 197 134 16 12
DIGOXIN 188 150 17 15
FAMOTIDINE 187 143 18 61
SPIRONOLACTONE 187 106 18 32
METFORMIN HCL 176 145 20 49
RANEXA 162 104 21 28
POTASSIUM CHLORIDE 155 129 22 21
HYDRALAZINE HCL 138 123 23 19
PRAVASTATIN SODIUM 133 100 24 13
GABAPENTIN 130 113 25 59
ZOLPIDEM TARTRATE 126 80 26 55
PANTOPRAZOLE SODIUM 122 102 27 25
TRAMADOL HCL-ACETAMINOPHEN 118 82 28 76
LOSARTAN POTASSIUM 112 106 29 17
NEXIUM 110 93 30 43
JANUVIA 108 65 31 83
DIOVAN 100 81 32 22
CLONIDINE HCL 95 75 33 42
LOVAZA 92 69 34 41
ADVAIR DISKUS 91 80 35 85
ZETIA 91 78 35 23
FELODIPINE ER 85 85 37 65
AMIODARONE HCL 83 79 38 36
LISINOPRIL-HYDROCHLOROTHIAZIDE 81 51 39 38
DICLOFENAC SODIUM 80 65 40 90
NIFEDIPINE ER 76 60 41 33
DEXILANT 75 44 42 69
NITROSTAT 73 55 43 20
KLOR-CON M10 71 57 44 93
KLOR-CON 10 70 62 45 67
TRIAMTERENE-HCTZ 68 63 46 63
CITALOPRAM HBR 67 61 47 94
LOSARTAN-HYDROCHLOROTHIAZIDE 64 56 48 40
HYDROCODONE-ACETAMINOPHEN 64 50 S3 48 97
LOVASTATIN 63 57 50 57
BENICAR 61 42 51 75
METOCLOPRAMIDE HCL 59 39 52 99
KLOR-CON M20 57 47 53 31
PAROXETINE HCL 57 35 53 100
METOLAZONE 55 37 55 80
BYSTOLIC 54 40 56 35
CYCLOBENZAPRINE HCL 52 32 R 57 102
LIPITOR 52 40 57 27
AZITHROMYCIN 50 35 59 103
HYDROCHLOROTHIAZIDE 50 33 59 16
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 22, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.